SCHEMBL6153812

SCHEMBL6153812

COC(=O)Cc1ccc(Oc2cccc(NC(=S)N/N=C/c3cc(OCc4ccccc4)cc(OCc4ccccc4)c3)c2)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 7/20 0.49
KMT2A Q03164 7/20 0.49
ALDH1A1 P00352 6/20 0.49
GAA P10253 5/20 0.49
NPC1 O15118 4/20 0.49
RAB9A P51151 4/20 0.49
POLB P06746 2/20 0.49
MAPK1 P28482 2/20 0.48
STAT3 P40763 1/20 0.48
STAT1 P42224 1/20 0.48
MEN1 O00255 6/20 0.47
MAPT P10636 6/20 0.47
PKM P14618 1/20 0.47
NPSR1 Q6W5P4 3/20 0.46
L3MBTL1 Q9Y468 2/20 0.46
THRB P10828 3/20 0.45
SPHK2 Q9NRA0 1/20 0.45
SPHK1 Q9NYA1 1/20 0.45
HPGD P15428 1/20 0.45
KDM4E B2RXH2 2/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6663443 0.92 KMT2A (0.49) SMN1; SMN2KMT2AALDH1A1GAANPC1
SCHEMBL5556614 0.78 KDM4E (0.58) SMN1; SMN2KMT2AALDH1A1GAANPC1
SCHEMBL6153416 0.76 KMT2A (0.52) SMN1; SMN2KMT2AALDH1A1GAANPC1
SCHEMBL6153919 0.75 SMN1; SMN2 (0.54) SMN1; SMN2KMT2AALDH1A1RAB9AMEN1
SCHEMBL5556482 0.75 GAA (0.49) SMN1; SMN2KMT2AALDH1A1GAANPC1
SCHEMBL5556735 0.74 MAPT (0.48) SMN1; SMN2KMT2AALDH1A1GAANPC1
SCHEMBL8037910 0.73 ALOX5 (0.61) SMN1; SMN2ALDH1A1NPC1RAB9A
SCHEMBL6153663 0.71 PDE4A (0.43) KMT2AALDH1A1GAANPC1RAB9A
SCHEMBL392863 0.70 ALOX5 (0.66) SMN1; SMN2ALDH1A1NPC1RAB9ALMNA
SCHEMBL6156530 0.69 KMT2A (0.51) SMN1; SMN2KMT2AALDH1A1GAANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050065118-A1 Organosulfur inhibitors of tyrosine phosphatases METABASIS THERAPEUTICS, INC. 2005-03-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050065118-A1 Organosulfur inhibitors of tyrosine phosphatases PTPRS, PTPRJ, PTPRCAP SMN1; SMN2 2211/4885KMT2A 875/4885ALDH1A1 961/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.